-+ 0.00%
-+ 0.00%
-+ 0.00%

Lifeward Receives CE Mark For ReWalk 7 Exoskeleton; Expands Commercial Sales In Europe

Benzinga·09/08/2025 12:34:37
Listen to the news

Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that the company has received CE mark approval for the ReWalk 7 Personal Exoskeleton, clearing it for commercial sale in Europe. The seventh generation of the ReWalk, which includes innovative new and enhanced features such as cloud connectivity, push-button control, customizable walking speeds, and seamless activation of stairs and curbs, will now be available to European customers, who currently represent approximately 40% of Lifeward's exoskeleton sales. The majority of these sales are generated through Lifeward GmbH, where the process of reimbursement for personal exoskeletons has been broadly established for individuals in Germany.